Nina Tandon, ‘09SEAS, started her career in telecommunications after graduating from Cooper Union with a degree in Electrical Engineering. Originally hired for behind-the-scenes development at Avaya Labs, Nina ultimately contributed to customer service and helped design a new user interface. She then switched over to the biomedical field with a Fullbright Scholarship to work on the LibraNose, a device designed to “smell” lung cancer. She then moved on to get her PhD from Columbia in biomedical engineering.
EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. It’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. Epibone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.
Tandon has been published in Nature Protocols and Lab on a Chip and has been featured on CNN and in Wired and the Guardian. She has spoken three times at TED and at the Milken and Bloomberg tech conferences. She was named one of the 100 Most Creative People in Business by Fast Company, a Crain’s 40 under 40 people who have achieved success in business before turning 40, and a World Economic Forum Tech Pioneer. Learn more about Epibone’s advances on their website.